Showing 4,641 - 4,660 results of 4,913 for search '"Hodgkin's lymphoma"', query time: 0.15s Refine Results
  1. 4641

    Primary cutaneous follicle center lymphoma by Eline Pinheiro Weba Costa, Bethänia Dias de Lucena, Gabriela Athayde Amin, Maraya de Jesus Semblano Bittencourt, Leonidas Braga Dias Junior, Carla Andréa Avelar Pires

    Published 2017-10-01
    “…Studies have shown an increased incidence of non-Hodgkin lymphomas in the last decade. We report an infrequent case that should be kept as a differential diagnosis of patients with nodules and cutaneous papules.…”
    Get full text
    Article
  2. 4642

    Castleman's Disease: An Interesting Cause of Hematuria by Sotonye Karl Tolofari, Wai-Man Chow, Basharat Hussain

    Published 2015-03-01
    “…It is associated with a number of malignancies, including Kaposi sarcoma, non-Hodgkin's and Hodgkins lymphoma, and POEMS syndrome. This report describes the case of a 38 year old gentleman, presenting with painless hematuria. …”
    Get full text
    Article
  3. 4643

    Sub-categorization of Pediatric Small Round Blue Cell Tumors using Immunohistochemistry by Muhammad Mudassar, Shireen Hamid, Muhammad Sarwar Zia, Sadia Hameed, Muhammad Usman, Muhammad Asif Aleem

    Published 2022-09-01
    “…It includes Non-Hodgkins Lymphoma, Synovial Sarcoma, Ewings Sarcoma/ Primitive Neuroectodermal Tumor, Rhabdomyosarcoma, Hepatoblastoma, Retinoblastoma, Neuroblastoma, Neuroendocrine carcinoma, Nasopharyngeal Carcinoma, Desmoplastic Small Round Cell Tumor, Dysgerminoma, and Wilm's tumor. …”
    Get full text
    Article
  4. 4644

    Primary cutaneous centrofollicular lymphoma with a good response to radiotherapy by Cláudia Medeiros dos Santos Camargo, Lislaine Bomm, Leonardo Spagnol Abraham, Rafael Daher, Maria de Fátima Guimarães Scotelaro, Luna Azulay Abulafia

    Published 2013-12-01
    “…About 30% of non-Hodgkin lymphomas involve extranodal tissues, the skin being the second most affected body organ after the gastrointestinal tract (approximately 18%). …”
    Get full text
    Article
  5. 4645

    Review on taxol as the most important anticancer natural drug by A Yari Khosroshahi, B Habibi Khaniani, HA Naghdibadi

    Published 2006-05-01
    “…At present, this drug is one of the most important anticancer natural agents with different mechanism from other similar drugs, used for remedy of different cancers such as, melanoma, lung cancer, non-hodgkins lymphoma, meatus urinarius cancer, esophagus cancer, etc. …”
    Get full text
    Article
  6. 4646

    Early transformation event from follicular lymphoma: our experience of four cases by Anurag Mehta, Diksha Karki, Prathyusha Gudapati

    Published 2022-10-01
    “…Herein, we describe four such cases of FL that transformed into more aggressive B-cell non-Hodgkin lymphomas within six months of their initial diagnosis. …”
    Get full text
    Article
  7. 4647
  8. 4648

    Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia by Ana M. Della Rocca, Fernanda S. Tonin, Mariana M. Fachi, Alexandre F. Cobre, Vinicius L. Ferreira, Letícia P. Leonart, Giovanna Steffenello-Durigon, Joanita A. G. Del Moral, Luana Lenzi, Roberto Pontarolo

    Published 2021-06-01
    “…BL/L was a risk factor for the occurrence of SPCs as acute myeloid leukemias (4.6 (2.1–10.4; <i>p</i> < 0.001)), Hodgkin lymphomas (extranodal) (74.3 (10.0–549.8; <i>p</i> < 0.001)) and Kaposi sarcomas (35.1 (12.1–101.4; <i>p</i> < 0.001)). …”
    Get full text
    Article
  9. 4649

    An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas by Wei-Ting Liu, Han-Tang Wang, Yi-Hsuan Yeh, Tak-Wah Wong

    Published 2023-04-01
    “…Primary cutaneous lymphomas are rare non-Hodgkin lymphomas consisting of heterogeneous disease entities. …”
    Get full text
    Article
  10. 4650

    Surgery for non-Hodgkin’s lymphoma by Elroy Patrick Weledji, George Enow Orock

    Published 2015-07-01
    “…Non-Hodgkin lymphomas (NHLs) are a diverse group of blood cancers derived from lymphocytes that vary significantly in their severity. …”
    Get full text
    Article
  11. 4651

    Proteasome inhibitors: therapeutic strategy in chronic lymphoproliferative syndrome by Agnerys López Sacerio, Dumeivy García Sánchez

    Published 2016-07-01
    “…Today inhibitors of proteasome are a promising therapeutic target in the management of some varieties of non-Hodgkin lymphomas.…”
    Get full text
    Article
  12. 4652

    Management of Marginal Zone Lymphoma: A Canadian Perspective by Anthea Peters, Mary-Margaret Keating, Anna Nikonova, Sarah Doucette, Anca Prica

    Published 2023-02-01
    “…Marginal zone lymphomas (MZL) are a rare, heterogenous group of lymphomas, accounting for 5–17% of indolent non-Hodgkin lymphomas in the western world. They can be further divided into three subtypes: extranodal MZL, splenic MZL, and nodal MZL. …”
    Get full text
    Article
  13. 4653
  14. 4654

    Primary Malignant Lymphoma of the Uterus: A Case Report and Review of the Literature by Margriet Samama, Mariette van Poelgeest

    Published 2011-12-01
    “…Most cases are non-Hodgkin lymphomas of which diffuse large B-cell lymphomas are most commonly seen. …”
    Get full text
    Article
  15. 4655

    Primary lymphoma of the lingual tonsil: a case report by Sıdıka Deniz Micozkadıoğlu, Cem Özer, Emine Tuba Canbolat

    Published 2010-03-01
    “…Extranodal non-Hodgkin lymphomas of the head and neck are rare. Most of the oral cavity lymphomas originate from Waldeyer ring and present as a mass in the oropharynx or nasopharynx. …”
    Get full text
    Article
  16. 4656
  17. 4657

    SOCS1 gene mutations in patients with diffuse large B-cell lymphoma by O A Gavrilina, E E Zvonkov, B V Biderman, N A Severina, E N Parovichnikova

    Published 2015-07-01
    “…Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of diseases, which accounts for 30% of all non-Hodgkin lymphomas. Current molecular studies have confirmed that there are several DLBCL subtypes characterized by different cellular origin, cytogenetic profile, molecular genetic disorders, and different pathogenesis. …”
    Get full text
    Article
  18. 4658

    Results of radiotherapy in extranodal MALT lymphoma. A case report and literature review by A.A. Quézada Bautista, J.C. Lara Bejarano, J.A. García García, J.L. Gaxiola Sosa, A. López Azcarraga, M.Y. Bautista Hernández

    Published 2016-10-01
    “…Mucosa-associated lymphoid tissue (MALT) represents 8% of non-Hodgkin lymphomas (NHL), with 2% affecting the conjunctiva. …”
    Get full text
    Article
  19. 4659

    Primary Cutaneous CD 30+ Anaplastic Large Cell Lymphoma. A Case Report and Literature Review by Miguel Ángel Serra Valdés, Julian Manzur Katrib, Yordanka Aleaga Hernández

    Published 2014-03-01
    “…It accounts for a very small proportion of non-Hodgkins lymphomas. The case of an 80-year-old female patient whose diagnosis was established in 2006 because of lesions on the face and neck is presented. …”
    Get full text
    Article
  20. 4660

    Pulmonary T-cell lymphoma masquerading as eosinophilic pneumonitis by Najam Siddiqui, Kevin Charles, Ashley E Ferraro, Robert C Holladay, Jeremy C Johnson, Satish Kalanjeri

    Published 2019-01-01
    “…This is a general term used to describe a diverse group of T-cell-type lymphomas that would otherwise not be classified as a PTCL. Among non-Hodgkin's lymphomas, PTCL accounts for 12% of cases. PTCL-NOS accounts for approximately 25% of all PTCL cases. …”
    Get full text
    Article